| Date | Title | Description |
| 30.10.2024 | Wall St struggles for direction ahead of mega cap earnings | U.S. MarketsWall St struggles for direction ahead of mega cap earnings
By Abigail SummervilleOctober 30, 20246:31 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Traders work on the floor at the... |
| 30.10.2024 | Latest Updates of Viva Biotech's Portfolio Companies | HONG KONG, Oct. 30, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies... |
| 29.10.2024 | AbbVie’s Bold Move: Acquiring Aliada Therapeutics for CNS Breakthroughs | In a strategic maneuver that echoes the age-old adage, "the early bird catches the worm," AbbVie has set its sights on the burgeoning field of central nervous system (CNS) therapeutics. The Chicago-based pharmaceutical giant annou... |
| 29.10.2024 | Innovent Announces Results of a Phase 2 Study of Picankibart (Anti-IL-23p19 Antibody) in Plaque Psoriasis, Showing Efficacy in Patients with Prior Inadequate Response to IL-17 Biologics | SAN FRANCISCO and SUZHOU, China, Oct. 29, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for ... |
| 28.10.2024 | Lilly's Mounjaro® (tirzepatide) Approved in Hong Kong in KwikPen® Presentation for Chronic Weight Management and Type 2 Diabetes, Offering a New Option for the Treatment of Obesity, Overweight and Typ... | Adults taking Mounjaro in a clinical trial lost on average 48 lb. at the highest dose1,2
Mounjaro delivered superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials6-12
Mounjaro represents a new class of obesity and... |
| 26.10.2024 | The Dance of Wushu and Investment: A Tale of Cultural and Economic Resurgence in China | In the heart of China, two significant events unfolded recently, each a testament to the nation’s vibrant culture and its evolving economic landscape. The 13th Zhengzhou International Shaolin Wushu Festival and a series of incremental polic... |
| 25.10.2024 | A raft of incremental policies lit up the confidence of foreign investors | BEIJING, Oct. 25, 2024 /PRNewswire/ -- A news report from China.org.cn on a raft of incremental policies proposed by China recently:
 
A raft of incremental policies lit up the confidence of foreign investors
Re... |
| 24.10.2024 | HiveMQ Honors IoT Excellence with Inaugural MQTT Innovation Awards | 2024 MQTT Innovation Award Winners
Winners leverage the MQTT protocol for positive outcomes and business value in manufacturing, life sciences, and healthcare
BOSTON and LANDSHUT, Germany, Oct. 24, 2024 /PRNewswire-PRWeb/ -- HiveMQ, the glo... |
| 22.10.2024 | Sunbird Bio: $14 Million Closed To Advance Blood-Based Diagnostic Platform In Alzheimer’s Disease | Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve the diagnosis and treatment of neurological disorders and early-stage cancer, announced the closing of a $14 million financing round backed by t... |
| 19.10.2024 | The Dawn of a New Era in Drug Discovery: Sanyou Bio's Super-Trillion Molecule Library | In the bustling heart of Shanghai, a revolution is brewing in the world of pharmaceuticals. Sanyou Bio, under the visionary leadership of Lang Guojun, has unveiled a groundbreaking innovation: the super-trillion molecule library. This monum... |
| 17.10.2024 | Innovent Announces Phase 2 Clinical Study of Picankibart (IBI112) in Chinese Patients with Ulcerative Colitis Met Primary Endpoint | SAN FRANCISCO and SUZHOU, China, Oct. 17, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for ... |
| 16.10.2024 | Sunbird Bio Raises Additional $14M in Funding | Sunbird Bio, a Cambridge, MA-based biotechnology company developing proprietary blood-based technologies, raised additional $14M in funding.
The round was led by Eli Lilly and Company and EDBI, as well as continued participation from existi... |
| 15.10.2024 | Arda Therapeutics: Targeted Cell Depletion Therapy Company Raises $43 Million (Series A) | Arda Therapeutics, a pioneer in targeted cell depletion therapies for chronic diseases, announced the successful completion of a $43 million Series A funding round. This funding round was led by existing investor Andreessen Horowitz (a16z B... |
| 14.10.2024 | Fastenal and Eli Lilly: Two Titans of Industry on the Rise | In the world of stocks, two companies are making waves: Fastenal and Eli Lilly. Each stands tall in its respective field, showcasing resilience and innovation. Fastenal, a giant in inventory management, is poised to reclaim its all-time hig... |
| 14.10.2024 | US Tech Giants To Invest £6.3BN in UK Data Centres | US firms CyrusOne, ServiceNow, Cloud HQ and CoreWeave have announced the UK will be the home for their data infrastructure, worth a total of £6.3 billion.
These new data centres will provide the UK with more computing power and data storage... |
| 13.10.2024 | Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top Eli Lilly is the most valuable pharmaceutical company in the world. I believe the company has what it takes to stay there. |
In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world. It took that mantle from the long-held dominance by Johnson and Johnson (NYSE: JNJ) back in May of 2... |
| 10.10.2024 | KeyBioscience Announces Extension of Strategic Collaboration with Lilly | Companies to extend collaboration on DACRAs with an additional collaboration molecule and investigation of the DACRA platform within multiple indications
LUGANO, Switzerland, Oct. 10, 2024 /PRNewswire/ -- KeyBioscience and Eli Lilly and Com... |
| 10.10.2024 | US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal | Boards, Policy & RegulationGovernment
Regulatory Oversight
Mergers & Acquisitions
Health
US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal
By Jody GodoyOctober 10, 20241:18 PM UTCUpdated ago
Text
Small Text
Medium... |
| 10.10.2024 | Kurma Partners: First Closing Of €250 Million Biofund IV | Kurma Partners, an asset manager focused on improving human health, announced that it has raised EUR 140 million, completing the first closing of Biofund IV. By the final closing in 2025, Kurma aims to have raised a total of €250 million in... |
| 08.10.2024 | Innovent and Ask Pharm Announce Strategic Collaboration for Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer | SAN FRANCISCO and SUZHOU, China, Oct. 8, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for t... |
| 08.10.2024 | Investor duo launch new healthtech VC firm | Digital health investors David Buller and Laurent van Lerberghe have announced the launch of KELES. This new venture capital firm will focus on making digital health growth investments across Europe, with the aim of bridging the gap between... |
| 07.10.2024 | Operationalizing Innovative Biomarkers to Support Evolving Therapeutic and Diagnostic Landscape for Neurodegenerative Diseases, Upcoming Webinar Hosted by Xtalks | www.labcorp.com
In this free webinar, learn about the rapidly evolving landscape of Alzheimer's disease therapy development and treatment. Attendees will gain insights into the key considerations for various platforms and strategies to inco... |
| 04.10.2024 | Igniting Futures: The Power of STEM Exploration Day | In a world where technology reigns supreme, the future hinges on innovation. The Children's Museum of Indianapolis recognized this truth by hosting STEM Exploration Day, a vibrant event designed to inspire young girls to embrace careers in ... |
| 03.10.2024 | Kurma Partners raises €140 million first close of new €250 million Biofund IV | Paris-based Kurma Partners, an asset manager focused on improving human health, announced that it has raised €140 million, successfully completing the first closing of Biofund IV. Kurma aims to have raised a total of €250 million in its new... |
| 01.10.2024 | Innovent's Picankibart: A New Dawn for Psoriasis Treatment in China | In the ever-evolving landscape of biopharmaceuticals, Innovent Biologics has emerged as a beacon of hope for millions suffering from moderate to severe plaque psoriasis. The company recently announced that its New Drug Application (NDA) for... |
| 01.10.2024 | Aktis Oncology: $175 Million (Series B) Secured To Develop Targeted Alpha Radiopharmaceuticals For Treating Tumors | Aktis Oncology, a clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, announced the successful closing of an oversubscribed and u... |
| 30.09.2024 | Aktis Oncology Raises $175M in Series B Funding | Aktis Oncology, a Boston, MA-based clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, closed a $175m Series B financing.
The rou... |
| 29.09.2024 | STEM Exploration Day Ignite Girls Passion for Careers in STEM | STEM Day at The Children's Museum of Indianapolis
Professional women with careers in science, technology, engineering and math make a world of difference in inspiring young girls to show them they can achieve anyything they want to with har... |
| 27.09.2024 | Capturing Time: A Journey Through Photography at SIPF 2024 and UIndy’s Night Calls | In the realm of photography, moments are fleeting. They slip through our fingers like grains of sand. Yet, two recent exhibitions—SIPF 2024 in Singapore and "Night Calls" at the University of Indianapolis—capture these moments, we... |
| 26.09.2024 | Innovent Announces NMPA Acceptance of NDA for Picankibart (Anti-IL-23p19 Antibody) for Treating Moderate to Severe Plaque Psoriasis | SAN FRANCISCO and SUZHOU, China, Sept. 26, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for... |
| 25.09.2024 | Vanderbilt University School of Medicine Basic Sciences Adds Carterra's LSAXT Instrument to Speed Drug and Vaccine Research and Advance Patient Care | The Center for Structural Biology in the School of Medicine Basic Sciences will be a hub of research innovation using Carterra's platform in traditional and AI-driven workflows for characterizing both antibodies and other biomolecules
SALT ... |
| 25.09.2024 | UIndy hosts worldwide art debut of Hoosier artist's homage to rural Indiana | A woman enjoys the "Night Calls" exhibit on the University of Indianapolis campus.
The University of Indianapolis has opened the worldwide debut of the exhibition entitled "Night Calls" featuring native Hoosier artist Re... |
| 25.09.2024 | Synple chem joins US-based eMolecules |
Founded by Benedikt Wanner (Founder & CEO) AND Paula Nichols (Co-founder and CCO) along with their team, Synpl Chem is a pioneering Zurich-based company that specializes in automated chemical synthesis for small molecules drug discover... |
| 25.09.2024 | Ученые обнаружили, что заразные формы рака вызваны изменением окружающей среды | У медузоподобных существ, называемых гидрами, при избыточном питании могут развиваться опухоли, которые, в свою очередь, могут передаваться их потомству. Новое исследование, посвященное этому явлению не только раскрыло подробности процесса ... |
| 20.09.2024 | US FTC sues drug 'gatekeepers' over high insulin prices | Healthcare & PharmaceuticalsHealth
Health Insurance
Healthcare Providers
Litigation
US FTC sues drug 'gatekeepers' over high insulin prices
By Jody Godoy and Ahmed AbouleneinSeptember 20, 20248:06 PM UTCUpdated ago
Text
Small Text
Mediu... |
| 19.09.2024 | Innovent Biologics: Pioneering New Frontiers in Cancer Treatment | In the world of oncology, the quest for effective treatments is relentless. Innovent Biologics, a biopharmaceutical company based in China, is at the forefront of this battle. Recently, they presented groundbreaking clinical data at the 202... |
| 19.09.2024 | Радиофармацевтические препараты назвали прорывом в борьбе с раком | Производители лекарств делают ставку на то, что доставка радиации непосредственно к опухолям станет следующим большим прорывом в борьбе с раком. Bristol Myers Squibb, AstraZeneca, Eli Lilly и другие фармацевтические компании потратили около... |
| 18.09.2024 | Innovent Announces Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Combined with Bevacizumab in Advanced Colorectal Cancer at the 2024 ESMO Congress | SAN FRANCISCO and SUZHOU, China, Sept. 18, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for... |
| 18.09.2024 | Innovent Delivers Oral Presentations on Clinical Data of IBI354 (HER2 Monoclonal Antibody-Camptothecin Derivative Conjugate) in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors at the 202... | SAN FRANCISCO and SUZHOU, China, Sept. 18, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for... |
| 12.09.2024 | Lilly expands manufacturing footprint in Ireland with $1.8 billion investment | Company ups manufacturing investment in Limerick by $1 billion; unveils new $800 million Kinsale facility
New investment will enhance global medicine production, benefiting millions of patients worldwide
INDIANAPOLIS, Sept. 12, 2024 /PRNews... |
| 12.09.2024 | Head-to-head Superiority over Dulaglutide: Innovent's Phase 3 Clinical Trial DREAMS-2 of Mazdutide in Chinese Patients with Type 2 Diabetes were Orally Presented at EASD 2024 | SAN FRANCISCO and SUZHOU, China, Sept. 12, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatme... |
| 11.09.2024 | Cure® Announces 2024 XSeed Award Winners, Promoting Women- and Minority-Led Life Science Startups in New York City | Teams led by Carol M. Troy, MD, PhD, of Columbia University Medical Center, and Paraskevi Giannakakou, PhD, of Weill Cornell Medical College, each to receive $250,000 grants
NEW YORK, Sept. 11, 2024 /PRNewswire/ -- Cure, a premier healthcar... |
| 11.09.2024 | Innovent Delivers Oral Presentation on Phase 1 Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer at the 2024 WCLC | SAN FRANCISCO and SUZHOU, China, Sept. 11, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for... |
| 10.09.2024 | NanoSyrinx: A New Dawn in Biotech with £10 Million Funding | In the world of biotechnology, innovation is the lifeblood. Today, a new player is making waves. NanoSyrinx, a synthetic biology company based in Coventry, UK, has successfully raised approximately £10 million (around $13 million) in a rece... |
| 10.09.2024 | NanoSyrinx Closes Approx. £10M Financing | NanoSyrinx, a Coventry, UK-based synthetic biology company, raised approx. £10M in funding.
The round was led by BGF, Octopus Ventures and M Ventures, with participation from new corporate investor, Eli Lilly and Company, and existing inves... |
| 10.09.2024 | Biotech firm NanoSyrinx raises £10M for nano syringe delivery platform | Synthetic biotech company NanoSyrinx, developers of nano syringes as a novel platform for targeted intracellular delivery of biologic therapeutics, today announced that it has closed a £10 million financing round.
NanoSyrinx’s platform is b... |
| 10.09.2024 | Дешевле, эффективнее и без уколов. Новый «Оземпик» на подходе | Кажется, что человечество стало еще на шаг ближе к исполнению «ленивых желаний». Никаких тренировок, никакой диеты – закинул таблетку и почти безвредно похудел. И если препарат Оземпик стоил дорого и вводился иглой, то теперь на рынке новый... |
| 10.09.2024 | Innovent Delivers Oral Presentation of Updated Results from a Pivotal Phase 2 Study of Dupert® (Fulzerasib) in Patients with Advanced Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation | SAN FRANCISCO and SUZHOU, China, Sept. 10, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for... |
| 10.09.2024 | NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman | Round co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and existing investors, IQ Capital and Meltwind
Appointment of Edwin Moses as Chairman to support the leadership team in ... |
| 10.09.2024 | Affinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial Officer | Industry veteran Daoud brings more than 25 years' experience in business development and corporate finance and strategy at multiple leading biopharmaceutical organizations
WALTHAM, Mass., Sept. 10, 2024 /PRNewswire/ -- Affinia Therapeutics ... |
| 09.09.2024 | Lilly appoints Lucas Montarce as executive vice president and chief financial officer | INDIANAPOLIS, Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO) and member of the company's Executive Committee, e... |
| 06.09.2024 | OrsoBio: $67 Million (Series B) Secured To Develop Treatments For Obesity | OrsoBio – a clinical-stage biopharmaceutical company developing treatments for obesity and obesity-associated disorders – announced the closing of an oversubscribed $67 million Series B financing. The funding was co-led by new investors Asc... |
| 05.09.2024 | HAYA Therapeutics and Lilly: A Game-Changer in Obesity Treatment | In a bold move, HAYA Therapeutics has struck a monumental deal with Eli Lilly, a titan in the pharmaceutical industry. This collaboration, valued at up to $1 billion, aims to tackle obesity and related metabolic disorders through innovative... |
| 05.09.2024 | Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs | :U.S. drugmaker Eli Lilly has signed a research deal with privately held AI-focused firm Genetic Leap to develop genetic medicines, the latter said on Thursday.
WHY IT'S IMPORTANT
Advertisement
Source: Reuters
Sign up for our newsletters
Ge... |
| 04.09.2024 | HAYA Therapeutics wins Major Collaboration with Lilly | Under the terms of the collaboration, HAYA will receive an upfront payment, including an equity investment, and is eligible to receive up to an aggregate $1 billion in pre-clinical, clinical and commercial milestone payments, as well as roy... |
| 04.09.2024 | HAYA Therapeutics secures USD 1 billion deal with Lilly to target obesity through RNA platform | HAYA Therapeutics, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics for chronic diseases, today announced a multi-year agreement with Eli Lilly and Company to apply HAYA’s advanced RNA-guided ... |
| 04.09.2024 | Lilly and EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries | Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases across 49 low- to middle-income countries in Africa
INDIANAPOLIS and CAIRO, Sept. 4, 2... |
| 03.09.2024 | SKIES ACROSS NORTH AMERICA TO LIGHT UP THIS FALL IN SUPPORT OF BLOOD CANCER PATIENTS | The Leukemia & Lymphoma Society kicks off philanthropic campaign Light The Night; communities nationwide encouraged to learn why awareness and support is critical
RYE BROOK, N.Y., Sept. 3, 2024 /PRNewswire/ -- The Leukemia & Lymphom... |
| 03.09.2024 | Pharmaceutical Market: Trends, Segmentation, and Growth Opportunities | Share
Tweet
Share
Share
Email
In recent years, the pharmaceutical market has witnessed remarkable growth and transformation, driven by technological advancements, evolving consumer needs, and the global push for better healthcare solutions.... |
| 02.09.2024 | Tech market values fall on AI costs and recession fears; Eli Lilly, Berkshire gain | U.S. MarketsTech market values fall on AI costs and recession fears; Eli Lilly, Berkshire gain
By ReutersSeptember 2, 202412:09 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Item 1 of 3 The lo... |
| 02.09.2024 | Tech market values fall on AI costs and recession fears; Eli Lilly, Berkshire gain | Previous
FILE PHOTO: Berkshire Hathaway logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., May 10, 2023. REUTERS/Brendan McDermid/File Photo
FILE PHOTO: The logo for Google is seen at th... |
| 02.09.2024 | Innovent Annouces Multiple Clinical Study Results of Mazdutide to be Presented at the EASD 2024 | SAN FRANCISCO and SUZHOU, China, Sept. 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for ... |
| 30.08.2024 | Health | Wegovy reduced COVID deaths in obese patients, study shows | “It’s not just weight loss, it’s not just diabetes,” said Ryan, who was on Novo’s steering committee for the Select trial and has consulted for other pharmaceutical companies. The effect of the drug is “much broader.”
Lilly has begun explor... |
| 30.08.2024 | Weekly Recap: 11 Press Releases You Might Have Missed | A roundup of the most newsworthy press releases from PR Newswire this week, including new Zepbound® single-dose vials, Pizza Hut's Moving Box Table and a Starliner update from NASA.
NEW YORK, Aug. 30, 2024 /PRNewswire/ -- With thousands of ... |
| 29.08.2024 | Innovent and Lilly: Pioneering Paths in Biopharmaceuticals | In the ever-evolving landscape of biopharmaceuticals, two companies stand out: Innovent Biologics and Eli Lilly. Both are making waves, each with a unique approach to tackling pressing health issues. Innovent, based in Suzhou, China, is car... |
| 29.08.2024 | Navigating the New Normal: COVID Vaccines and Creative Leadership in Healthcare | The landscape of healthcare marketing is shifting. Imre, a prominent brand engagement agency, has made significant strides by appointing Tracy Zuto and Malia Baker as key creative leaders. Their arrival signals a commitment to innovative, i... |
| 29.08.2024 | Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024 | SAN FRANCISCO and SUZHOU, China, Aug. 29, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for ... |
| 28.08.2024 | A New Dawn for America's National Parks: $100 Million Grant to Combat Overtourism | The U.S. National Park Foundation has received a monumental $100 million grant from Lilly Endowment Inc. This is not just a sum; it’s a lifeline. It aims to tackle the pressing issue of overtourism in America’s cherished national parks. The... |
| 28.08.2024 | Imre announced two new appointments to Strengthen Brand AOR Expertise | Imre continues its commitment to cutting-edge creative that builds brand engagement with the appointment of two senior creative leaders, as the agency strengthens its position as a distinct choice for agency-of-record assignments in healthc... |
| 28.08.2024 | Innovent Announces 2024 Interim Results and Business Updates | Strong commercial performance and significant pipeline milestones
support sustained growth and innovation
SAN FRANSISCO and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopha... |
| 28.08.2024 | Warren Buffett's Company Is Worth $1 Trillion For the First Time — But He May Not Be Celebrating Berkshire Hathaway's sustained growth has made it the seventh-most-valuable U.S. public company. |
This article originally appeared on Business Insider.
Warren Buffett's conglomerate surpassed $1 trillion in market value for the first time, spotlighting the investor's extraordinary success over nearly six decades.
Berkshire Hathaway's C... |
| 27.08.2024 | Imre Appoints Powerhouse Leaders Tracy Zuto and Malia Baker and Strengthens Brand AOR Expertise | New Additions Reflect Commitment to Creative Excellence and Healthcare Industry Leadership
NEW YORK, Aug. 27, 2024 /PRNewswire/ -- Imre continues its commitment to cutting-edge creative that builds brand engagement with the appointment of t... |
| 27.08.2024 | Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity | Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity
INDIANAPOLIS, Aug. 27, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: L... |
| 26.08.2024 | National Park Foundation Receives Historic $100 Million Grant from Lilly Endowment Inc. | The grant will support the Foundation's mission to ensure national parks are protected, accessible, and welcoming — today and for future generations.
WASHINGTON, Aug. 26, 2024 /PRNewswire/ -- The National Park Foundation (NPF) today announc... |
| 23.08.2024 | The Future of Innovation: Partnerships and Events Shaping Tomorrow's Landscape | In the fast-paced world of biotechnology and advertising, collaboration and innovation are the lifeblood of progress. Two recent developments illustrate this dynamic: Oblique Therapeutics' partnership with Eli Lilly and Smartly's upcoming f... |
| 23.08.2024 | Smartly Announces Industry Flagship Event in NYC on September 18th 2024 | Smartly, the AI-powered advertising technology company, today announced its flagship event for the advertising industry, ADVANCE. Taking place on Wednesday, September 18th, 2024, at Skylight at Essex Crossing in New York City, ADVANCE will ... |
| 22.08.2024 | Oblique Therapeutics has entered a research collaboration agreement with Eli Lilly and Company to apply the AbiProt[®] technology to generate antibodies to a high-value target | Oblique Therapeutics has entered a research collaboration agreement with Eli Lilly and Company to apply the AbiProt[®] technology to generate antibodies to a high-value target
Thu, Aug 22, 2024 12:59 CET Report this content
Stockholm, Swede... |
| 22.08.2024 | China's First Approved KRAS G12C Inhibitor: Innovent Announces the Approval of Dupert® (Fulzerasib) by the National Medical Products Administration of China | SAN FRANCISCO and SUZHOU, China, Aug. 22, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for ... |
| 21.08.2024 | Wall St ends lower ahead of Jackson Hole, snapping multi-session rally | U.S. MarketsWall St ends lower ahead of Jackson Hole, snapping multi-session rally
By Stephen CulpAugust 20, 202410:41 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
SummaryCompanies
Palo Alto ... |
| 19.08.2024 | TopBrand 2024 Top 500 Global Brands List released, with Apple as defending champion | GUANGZHOU, China, Aug. 19, 2024 /PRNewswire/ -- The 18th China Brand Festival was held during August 7th-10th, 2024 in Guangzhou. The theme of this brand festival is "New Quality and Breakthrough". More than 8,000 guests gathered ... |
| 19.08.2024 | Lilly Acquire Morphic | Eli Lilly and Company (NYSE: LLY), an Indianapolis, IN-based medicine company, acquired Morphic Holding, Inc. (NASDAQ: MORF), a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic diseases.
The amou... |
| 17.08.2024 | KNIME: Open-Source Data Science And AI Company Raises $30 Million | KNIME, one of the leading open-source data science and AI companies, announced it has raised additional funding from its longstanding investor, Invus. Since the last announcement, Invus has invested another $30 million, bringing the total f... |
| 17.08.2024 | Health | How little Denmark got homegrown giant Novo Nordisk to lower Ozempic prices | In Denmark, with prescriptions for the drugs gobbling up 18% of regional drug budgets in 2023, officials were considering the unthinkable in a system that prides itself on free cradle-to-grave coverage: forcing patients to pay out-of-pocket... |
| 16.08.2024 | Weekly Recap: 11 Press Releases You Might Have Missed | A roundup of the most newsworthy press releases from PR Newswire this week, including the state of America's well-being, the winter weather forecast and housing market updates.
NEW YORK, Aug. 16, 2024 /PRNewswire/ -- With thousands of press... |
| 16.08.2024 | IONETIX: Cyclotron Company Raises Funding Led By Tees River And Lilly | IONETIX, a leading cyclotron technology innovator and isotope manufacturer for diagnostic and therapeutic applications, announced a round of funding. The investors included Eli Lilly and Company and existing shareholders led by Tees River L... |
| 16.08.2024 | Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease | Broadens Lilly's immunology pipeline with Morphic's oral integrin therapies, including MORF-057
Reinforces the company's strategy of delivering potential first or best-in-class therapies in the field of gastroenterology
INDIANAPOLIS, Aug. 1... |
| 15.08.2024 | Lilly's New Innovation Center: A Beacon for Biotech in Boston | Eli Lilly and Company has unveiled a new chapter in its storied history with the opening of the Lilly Seaport Innovation Center (LSC) in Boston. This state-of-the-art facility is not just a building; it’s a lighthouse guiding the future of ... |
| 15.08.2024 | Invus invests additional $30M in Knime |
KNIME helps everybody make sense of data. Its free and open-source KNIME Analytics Platform enables anyone – from business to technical and data backgrounds – to intuitively work with data. KNIME Hub is the commercial complement to KNIME A... |
| 13.08.2024 | Lilly opens state-of-the-art research and development center in the Boston Seaport | Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs
New 346,000 square foot facility will accommodate approximately 500 Lilly scientists an... |
| 12.08.2024 | Artax Biopharma: $8 Million Raised To Transform Treatment Of Autoimmune Diseases | Artax Biopharma, a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, announced the closing of an $8 million convertible debt financing, supported by Eli Lilly and Company, Advent Life Science... |
| 08.08.2024 | Indexes rally, close higher after US jobless claims data | U.S. MarketsIndexes rally, close higher after US jobless claims data
By Caroline ValetkevitchAugust 8, 20248:00 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Item 1 of 2 Traders work on the fl... |
| 08.08.2024 | Lilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion | Revenue in Q2 2024 increased 36%, driven by Mounjaro, Zepbound and Verzenio. When excluding $579.0 million of revenue from the sale of rights for Baqsimi in Q2 2023, revenue in Q2 2024 increased 46%. Excluding the sale of rights for Baqsimi... |
| 08.08.2024 | Fierce Competition and Technological Innovation Drive Diabetes Care Devices Market Towards Explosive Growth | OEMs Leading the Charge with AI-Equipped Technology and Novel Business Strategies
SAN ANTONIO, Aug. 8, 2024 /PRNewswire/ -- The diabetes care devices industry is witnessing a dynamic evolution, marked by intense competition among establishe... |
| 07.08.2024 | The Surge of Innovation: A Look at Recent Startup Funding in India | The Indian startup ecosystem is buzzing. Recent funding rounds showcase a diverse array of sectors, from medtech to agritech, and even dating apps. Investors are eager to back innovative ideas. The landscape is shifting, and the stakes are ... |
| 07.08.2024 | KNIME's Bold Leap into the Future of AI Governance | In the fast-paced world of artificial intelligence, the race is on. Companies are scrambling to harness the power of AI while managing its risks. KNIME, a leader in open-source data science, has just made a significant move. The company sec... |
| 07.08.2024 | Morning Bid: BOJ eases market migraine, Super Micro aches | A look at the day ahead in U.S. and global markets from Mike Dolan
In an extraordinary round trip over the past week, world markets have rebounded sharply from days of turbulence - thanks in part to Bank of Japan almost apologising on Wedne... |
| 06.08.2024 | Open-source data science platform Knime raises $30M to seize opportunity in generative AI
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mi... | Open-source data science platform provider Knime AG said today it has closed on a new, $30 million investment from its longtime backer Invus.
The round is the first major investment the company has received since Invus led its initial Serie... |
| 06.08.2024 | KNIME Secures Investment to Accelerate Enterprise AI Governance and ModelOps | KNIME, one of the leading open-source data science and AI companies, has raised additional funding from its longstanding investor Invus. Since the last announcement, Invus invested another $30M, bringing total funding to $50M. This will all... |
| 06.08.2024 | Artax Biopharma Raises $8 Million Ahead of Phase 2a Data Expected in Q4-2024 | Strong support from existing shareholders which includes Lilly, Advent Life Sciences, Columbus Ventures, Sound Bioventures and Belinda Termeer
CAMBRIDGE, Mass., Aug. 6, 2024 /PRNewswire/ -- Artax Biopharma, Inc., a clinical-stage biotechnol... |
| 05.08.2024 | AI chip startup Groq valued at $2.8 billion after latest funding round | ETtech
Semiconductor startup Groq said on Monday it has raised $640 million in a Series D funding round led by Cisco Investments, Samsung Catalyst Fund and BlackRock Private Equity Partners, among others, bringing its valuation to $2.8 bill... |
